Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.81)
# 3,167
Out of 4,902 analysts
173
Total ratings
43.84%
Success rate
-2.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $3.54 | +12.99% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $89.53 | +19.51% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $135.81 | +8.24% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $94.90 | +0.11% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $516.16 | +25.93% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.85 | +21.83% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $112.52 | -15.57% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $86.96 | -2.25% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $30.85 | -51.38% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $283.45 | +21.01% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $3.09 | +353.07% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $27.89 | +72.10% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $76.18 | +33.89% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $104.65 | -44.58% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $14.18 | +41.04% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $84.10 | +55.77% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $120.51 | +10.36% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $388.90 | -43.43% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $113.59 | +232.78% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $3.54
Upside: +12.99%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $89.53
Upside: +19.51%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $135.81
Upside: +8.24%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $94.90
Upside: +0.11%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $516.16
Upside: +25.93%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.85
Upside: +21.83%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $112.52
Upside: -15.57%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $86.96
Upside: -2.25%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $30.85
Upside: -51.38%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $283.45
Upside: +21.01%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $3.09
Upside: +353.07%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $27.89
Upside: +72.10%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $76.18
Upside: +33.89%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $104.65
Upside: -44.58%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $14.18
Upside: +41.04%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $84.10
Upside: +55.77%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $120.51
Upside: +10.36%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $388.90
Upside: -43.43%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $113.59
Upside: +232.78%